NCT04375280|Recruiting
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
EVALMOB
Loading search results
EVALMOB
Sponsor study identifier
Secondary identifiers
OTHER · 2019-A01017-50
interventional
5,000
1 country
1
Study Start
August 27, 2020
Actual (reported)Primary Completion
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 27, 2020
Actual (reported)May 5, 2020
Actual (reported)August 27, 2020
Actual (reported)August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Day 0
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Month 6
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Participants will be involved in a long-term evaluation program combining, body composition measures, physical tests as well as self-administered questionnaires. Participants will be followed for 5 years with evaluations taking place at inclusion, 6 months, at 1, 2 and 5 years
Firstly, volunteers will be invited to complete online questionnaires on a secure platform. The mobility assessment will be carried out initially (t1) and up to a maximum of 4 times (t1 to t4) as part of a day hospitalization. Questionnaires will be diverse (SF36, KOOS, HOOS, BROCKER, MNA, TAMPA, etc.) in order to assess several aspects that compose mobility. Physical evaluations will include various validated tests (isokinetic strength measure, TUG, 6MWT, Berg Balance Scale, etc.)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Chu Clermont Ferrand
Clermont-Ferrand, 63003, France
Frédéric Costes
University Hospital, Clermont-Ferrand
First Submitted
April 27, 2020
First Posted
May 5, 2020
Study Start
August 27, 2020
Actual (reported)Primary Completion
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Year 1
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Year 2
dismobility score calculated from the results reported in secondary outcomes
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Year 5
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Day 0
Weight (Kg).
Day 0
Weight (Kg).
Month 6
Weight (Kg).
Year 1
Weight (Kg).
Year 2
Contact the study team to confirm eligibility.
Study Completion
August 26, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 28, 2025
Record last verified: 2025-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: